|
1
|
Ikezumi Y, Suzuki T, Karasawa T, Yamada T,
Hasegawa H, Nishimura H and Uchiyama M: Low birthweight and
premature birth are risk factors for podocytopenia and focal
segmental glomerulosclerosis. Am J Nephrol. 38:149–157. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ma R, Liu L, Liu X, Wang Y, Jiang W and Xu
L: Triptolide markedly attenuates albuminuria and podocyte injury
in an animal model of diabetic nephropathy. Exp Ther Med.
6:649–656. 2013.PubMed/NCBI
|
|
3
|
Sirin Y and Susztak K: Notch in the
kidney: development and disease. J Pathol. 226:394–403. 2012.
View Article : Google Scholar
|
|
4
|
Niranjan T, Bielesz B, Gruenwald A, Ponda
MP, Kopp JB, Thomas DB and Susztak K: The Notch pathway in
podocytes plays a role in the development of glomerular disease.
Nat Med. 14:290–298. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhou W, Wang G and Guo S: Regulation of
angiogenesis via Notch signaling in breast cancer and cancer stem
cells. Biochim Biophys Acta. 1836:304–320. 2013.PubMed/NCBI
|
|
6
|
Ji X, Wang Z, Geamanu A, Sarkar FH and
Gupta SV: Inhibition of cell growth and induction of apoptosis in
non-small cell lung cancer cells by delta-tocotrienol is associated
with notch-1 down-regulation. J Cell Biochem. 112:2773–2783. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang W, Li L, Zhou Z, Gao J and Sun Y:
Effect of spironolactone combined with angiotensin-converting
enzyme inhibitors and/or angiotensin II receptor blockers on
chronic glomerular disease. Exp Ther Med. 6:1527–1531.
2013.PubMed/NCBI
|
|
8
|
Ding Y, Stidham RD, Bumeister R, Trevino
I, Winters A, Sprouse M, Ding M, Ferguson DA, Meyer CJ, Wigley WC
and Ma R: The synthetic triterpenoid, RTA 405, increases the
glomerular filtration rate and reduces angiotensin II-induced
contraction of glomerular mesangial cells. Kidney Int. 83:845–854.
2013. View Article : Google Scholar :
|
|
9
|
Siragy HM and Carey RM: Role of the
intrarenal renin-angiotensin-aldosterone system in chronic kidney
disease. Am J Nephrol. 31:541–550. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang S, Yao B, Zhou Y, Yin H, Zhang MZ and
Harris RC: Intrarenal dopamine modulates progressive angiotensin
II-mediated renal injury. Am J Physiol Renal Physiol.
302:F742–F749. 2012. View Article : Google Scholar :
|
|
11
|
Koshizaka M, Takemoto M, Sato S, Tokuyama
H, Fujimoto M, Okabe E, Ishibashi R, Ishikawa T, Tsurutani Y,
Onishi S, Mezawa M, He P, Honjo S, Ueda S, Saito Y and Yokote K: An
angiotensin II type 1 receptor blocker prevents renal injury via
inhibition of the Notch pathway in Ins2 Akita diabetic mice. Exp
Diabetes Res. 2012:1598742012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou TB, Qin YH, Lei FY, Su LN, Zhao YJ
and Huang WF: Less gelatinases is associated with apolipoprotein E
accumulation in glomerulosclerosis rats. Histol Histopathol.
27:249–256. 2012.
|
|
13
|
Ji L, Yin XX, Wu ZM, Wang JY, Lu Q and Gao
YY: Ginkgo biloba extract prevents glucose-induced accumulation of
ECM in rat mesangial cells. Phytother Res. 23:477–485. 2009.
View Article : Google Scholar
|
|
14
|
Wang B, Komers R, Carew R, Winbanks CE, Xu
B, Herman-Edelstein M, Koh P, Thomas M, Jandeleit-Dahm K,
Gregorevic P, Cooper ME and Kantharidis P: Suppression of
microRNA-29 expression by TGF-β1 promotes collagen expression and
renal fibrosis. J Am Soc Nephrol. 23:252–265. 2012. View Article : Google Scholar :
|
|
15
|
Schena FP and Gesualdo L: Pathogenetic
mechanisms of diabetic nephropathy. J Am Soc Nephrol. 16(Suppl 1):
S30–S33. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Singh LP, Green K, Alexander M, Bassly S
and Crook ED: Hexosamines and TGF-beta1 use similar signaling
pathways to mediate matrix protein synthesis in mesangial cells. Am
J Physiol Renal Physiol. 286:F409–F416. 2004. View Article : Google Scholar
|
|
17
|
Han SY, Jee YH, Han KH, Kang YS, Kim HK,
Han JY, Kim YS and Cha DR: An imbalance between matrix
metalloproteinase-2 and tissue inhibitor of matrix
metalloproteinase-2 contributes to the development of early
diabetic nephropathy. Nephrol Dial Transplant. 21:2406–2416. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu GX, Li YQ, Huang XR, Wei L, Chen HY,
Shi YJ, Heuchel RL and Lan HY: Disruption of Smad7 promotes Ang
II-mediated renal inflammation and fibrosis via
Sp1-TGF-β/Smad3-NF-κB-dependent mechanisms in mice. PLoS One.
8:e535732013. View Article : Google Scholar
|
|
19
|
Mundel P, Reiser J, Zúñiga Mejía Borja A,
Pavenstädt H, Davidson GR, Kriz W and Zeller R: Rearrangements of
the cytoskeleton and cell contacts induce process formation during
differentiation of conditionally immortalized mouse podocyte cell
lines. Exp Cell Res. 236:248–258. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cheng HT, Kim M, Valerius MT, Surendran K,
Schuster-Gossler K, Gossler A, McMahon AP and Kopan R: Notch2, but
not Notch1, is required for proximal fate acquisition in the
mammalian nephron. Development. 134:801–811. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Arumugam TV, Chan SL, Jo DG, Yilmaz G,
Tang SC, Cheng A, Gleichmann M, Okun E, Dixit VD, Chigurupati S,
Mughal MR, Ouyang X, Miele L, Magnus T, Poosala S, Granger DN and
Mattson MP: Gamma secretase-mediated Notch signaling worsens
braindamage and functional outcome in ischemic stroke. Nat Med.
12:621–623. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gao F, Yao M, Shi Y, Hao J, Ren Y, Liu Q,
Wang X and Duan H: Notch pathway is involved in high
glucose-induced apoptosis in podocytes via Bcl-2 and p53 pathways.
J Cell Biochem. 114:1029–1038. 2013. View Article : Google Scholar
|
|
23
|
Lennon R, Byron A, Humphries JD, Randles
MJ, Carisey A, Murphy S, Knight D, Brenchley PE, Zent R and
Humphries MJ: Global analysis reveals the complexity of the human
glomerular extracellular matrix. J Am Soc Nephrol. 25:939–951.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cheng S, Pollock AS, Mahimkar R, Olson JL
and Lovett DH: Matrix metalloproteinase 2 and basement membrane
integrity: a unifying mechanism for progressive renal injury. FASEB
J. 20:1898–1900. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tsai JP, Liou JH, Kao WT, Wang SC, Lian JD
and Chang HR: Increased expression of intranuclear matrix
metalloproteinase 9 in atrophic renal tubules is associated with
renal fibrosis. PLoS One. 7:e481642012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kuan TC, Chen MY, Liao YC, Ko L, Hong YH,
Yen CY, Hsieh WY, Cheng KS, Wu CL and Lin CS: Angiotensin II
down-regulates ACE2-mediated enhancement of MMP-2 activity in human
cardiofibroblasts. Biochem Cell Biol. 91:435–442. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Solini A, Rossi C, Santini E, Madec S,
Salvati A and Ferrannini E: Angiotensin-II and rosuvastatin
influence matrix remodeling in human mesangial cells via
metalloproteinase modulation. J Hypertens. 29:1930–1939. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Czech KA, Bennett M and Devarajan P:
Distinct metalloproteinase excretion patterns in focal segmental
glomerulosclerosis. Pediatr Nephrol. 26:2179–2184. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sun H, Ge N, Shao M, Cheng X, Li Y, Li S
and Shen J: Lumbrokinase attenuates diabetic nephropathy through
regulating extracellular matrix degradation in
Streptozotocin-induced diabetic rats. Diabetes Res Clin Pract.
100:85–95. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhou L, Zhang N, Song W, You N, Li Q, Sun
W, Zhang Y, Wang D and Dou K: The significance of Notch1 compared
with Notch3 in high metastasis and poor overall survival in
hepatocellular carcinoma. PLoS One. 8:e573822013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tang DQ, Wei YQ, Yin XX, Lu Q, Hao HH,
Zhai YP, Wang JY and Ren J: In vitro suppression of quercetin on
hypertrophy and extracellular matrix accumulation in rat glomerular
mesangial cells cultured by high glucose. Fitoterapia. 82:920–926.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Herman-Edelstein M, Thomas MC,
Thallas-Bonke V, Saleem M, Cooper ME and Kantharidis P:
Dedifferentiation of immortalized human podocytes in response to
transforming growth factor-β: a model for diabetic podocytopathy.
Diabetes. 60:1779–1788. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Morales MG, Abrigo J, Meneses C, Simon F,
Cisternas F, Rivera JC, Vazquez Y and Cabello-Verrugio C: The
Ang-(1–7)/Mas-1 axis attenuates the expression and signalling of
TGF-β1 induced by AngII in mouse skeletal muscle. Clin Sci (Lond).
127:251–264. 2014. View Article : Google Scholar
|
|
34
|
Matsumoto E, Sasaki S, Kinoshita H, Kito
T, Ohta H, Konishi M, Kuwahara K, Nakao K and Itoh N: Angiotensin
II-induced cardiac hypertrophy and fibrosis are promoted in mice
lacking Fgf16. Genes Cells. 18:544–553. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Aoyagi-Ikeda K, Maeno T, Matsui H, Ueno M,
Hara K, Aoki Y, Aoki F, Shimizu T, Doi H, Kawai-Kowase K, Iso T,
Suga T, Arai M and Kurabayashi M: Notch induces myofibroblast
differentiation of alveolar epithelial cells via transforming
growthfactor-{beta}-Smad3 pathway. Am J Respir Cell Mol Biol.
45:136–144. 2011.PubMed/NCBI
|
|
36
|
Chen Y, Zheng S, Qi D, Zheng S, Guo J,
Zhang S and Weng Z: Inhibition of Notch signaling by a γ-secretase
inhibitor attenuates hepatic fibrosis in rats. PLoS One.
7:e465122012. View Article : Google Scholar
|
|
37
|
Tsioufis C, Bafakis I, Kasiakogias A and
Stefanadis C: The role of matrix metalloproteinases in diabetes
mellitus. Curr Top Med Chem. 12:1159–1165. 2012. View Article : Google Scholar : PubMed/NCBI
|
